TITLE

Early Medical Abortion Regimens Using Different Dosages of Mifepristone Are Equally Successful

AUTHOR(S)
K., Mahler
PUB. DATE
September 2000
SOURCE
Family Planning Perspectives;Sep/Oct2000, Vol. 32 Issue 5, p259
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article focuses on early medical abortion regimens using different dosages of mifepristone are equally successful. A regimen of medical abortion consisting of 200 mg of mifepristone and 400 mg of misoprostol is as likely to successfully terminate an early pregnancy as a regimen using the same dosage of misoprostol and 600 mg of mifepristorie. In a study of treatment effectiveness conducted at 17 centers worldwide, 89% of women treated with the lower dose of mifepristone and 88% of those treated with the higher dose of the drug had a complete abortion. The proportion of women in each group who experienced side effects such as lower abdominal pain, nausea, vomiting and diarrhea was similar. The success of both of the regimens was related to gestational age--the risk of a continuing pregnancy was more than twice as high among women who received treatment 4-5 weeks after the expected date of menses as it was among those who were treated no more than 15 days after they missed their menstrual period. Eighty-nine percent of women who received the 200 mg dose of mifepristone and 88% of those who received the 600 mg dose had a complete abortion without surgical intervention.
ACCESSION #
3621777

 

Related Articles

  • Regimen Employing a Fraction of the Standard Dose Of Mifepristone Is a Successful Early Abortion Method. Hollander, D. // Family Planning Perspectives;Jul/Aug99, Vol. 31 Issue 4, p204 

    This article focuses on how a medical abortion method using one-third the standard dose of oral mifepristone followed by vaginally administered misoprostol is highly effective within the first eight weeks of pregnancy. In a multicenter study of the modified regimen, 97 percent of women had...

  • The steroid RU486 induces UCP1 expression in brown adipocytes. Rodríguez, Ana; Palou, Andreu // Pflugers Archiv European Journal of Physiology;Nov2004, Vol. 449 Issue 2, p170 

    RU486 (mifepristone), a potent antagonist at progesterone and glucocorticoid receptors (PR and GR), is well known for its use in the termination of unwanted pregnancies, the potential development of oral contraceptives, treatment of certain cancers and other activities. Potentially, it could...

  • Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomized study. Christina Rrbye; Mogens Nrgaard; Lisbeth Nilas // Human Reproduction;Mar2005, Vol. 20 Issue 3, p834 

    BACKGROUND: The aim of the study was to compare satisfaction with medical and surgical abortion and to identify potential confounders affecting satisfaction. METHODS: 1033 women with gestational age (GA) =63 days had either a medical (600?mg mifepristone followed by 1?mg gemeprost) or a surgical...

  • In Brief. Hollander, Dore // Family Planning Perspectives;Mar/Apr97, Vol. 29 Issue 2, p51 

    This article reports developments related to the field of family planning. Although most Americans believe abortion should be legal in all or some circumstances (83 percent), they are evenly split in their opinions about whether mifepristone, commonly called the abortion pill, should be made...

  • Nonsurgical Abortion.  // New Harvard Guide to Women's Health;2004, p406 

    Presents a comprehensive women's health guide to nonsurgical abortion. Discussion on the procedure of nonsurgical abortion; Information on RU-486, an abortion pill or the French abortion pill; Side effects and health risks for using RU-486; Other nonsurgical alternatives for abortion.

  • Knowledge, Awareness, Perceptions, and Use of Emergency Contraceptives among Survivors of Intimate Partner Violence. Wilder, Kathleen J.; Guise, Jeane-Marie; Perrin, Nancy A.; Hanson, Ginger C.; Hernandez, Rebecca; Glass, Nancy // Obstetrics & Gynecology International;2009, Vol. 2009, p1 

    The study examines emergency contraception (EC) knowledge, awareness, perceptions, and prior use and identifies predictors of EC use among a sample of survivors of intimate partner violence (IPV). The majority (66.2%) of 154 survivors at risk of pregnancy reported EC awareness, only 15.3%...

  • Correcting Spontaneous Abortion Rates for the Presence of Induced Abortion. Figa-Talamanca, Irene; Repetto, Francesca // American Journal of Public Health;Jan1988, Vol. 78 Issue 1, p40 

    Abstract: This paper introduces a method for correcting spontaneous abortion rates by taking into consideration the fact that a number of spontaneous abortions are "prevented" by induced abortions. This correction may be important in settings of high induced abortion incidence. The method is...

  • MIFEPRISTONE AND MISOPROSTOL FOR TERMINATION OF EARLY PREGNANCY. Randel, Jaclyn; French, Linda // Journal of Family Practice;Aug1998, Vol. 47 Issue 2, p96 

    The article presents information on a study that aimed at both the safety and efficacy of a medical regimen employing mifepristone and misoprostol for inducing early pregnancy termination. The availability of a medical regimen for inducing abortion could lead to greater access to safer services...

  • Both unwanted pregnancies and abortions are common among women in Nigeria. Mahler, K. // International Family Planning Perspectives;Dec99, Vol. 25 Issue 4, p207 

    Reveals that both unwanted pregnancies and abortions are common among Nigerian women. Findings from a study conducted in the local governments of Ife and Jos; Comparison between women familiar with family planning and those ignorant of it with respect to reporting unwanted pregnancies; Factors...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics